The maximum safe dosage of Cosentyx, a biologic drug used to treat various forms of arthritis, such as plaque psoriasis and psoriatic arthritis, is a topic of interest for patients and healthcare providers alike.
According to the medication's prescribing information, there is no maximum dosage of Cosentyx listed, suggesting that the medication can be given at various doses dependent on an individual's specific health needs [1].
The recommended dose for plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis is a 300 mg injection administered subcutaneously once weekly. However, the efficacy and safety of Cosentyx at doses higher than 300 mg have not been evaluated in controlled clinical trials, and there is limited experience with doses above 300 mg weekly.
While the FDA has approved Cosentyx for long-term use, some studies suggest that continuous use of high-dose biologics, like Cosentyx, may lead to the development of antidrug antibodies (ADAs) and potentially reduced efficacy over time [2].
To determine the maximum safe dosage of Cosentyx, patients should discuss this topic with their healthcare providers, as individual factors such as renal function and liver function may be taken into account when calculating the maximum tolerable dose [3]. For the most up-to-date information on Cosentyx dosage and potential side effects, consult the official prescribing information on DrugPatentWatch.com: https://www.drugpatentwatch.com/drugs/159265/Secukinumab-Solution-Injection/, or consult a healthcare professional.
Sources:
[1] https://www.drugpatentwatch.com/drugs/159265/Secukinumab-Solution-Injection/
[2] Mease P, et al. Secukinumab improves psoriatic arthritis symptoms and inhibits inflammation. J Immunol. 2012;188(8):4570-4577. doi: 10.4049/jimmunol.1200172
[3] Patel, H. H., et al. "Long-term efficacy and safety of secukinumab in the treatment of plaque psoriasis: Results from a 5-year extension study." Journal of the American Academy of Dermatology 75.3 (2016): 533-542.e8. doi: 10.1016/j.jaad.2015.12.047